表紙
市場調査レポート

非小細胞肺癌:世界の治験レビュー

Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 229164
出版日 ページ情報 英文 295 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
非小細胞肺癌:世界の治験レビュー Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014
出版日: 2014年03月31日 ページ情報: 英文 295 Pages
概要

当レポートでは、非小細胞肺癌に関する臨床研究の最新動向について分析し、疾患の概要をはじめ、地域および主要国における治験の状況、フェーズ(相)・進捗状況別の治験データ、被験者の募集状況、有望なスポンサー、そして各企業・研究機関の治験プロファイルなどの情報を盛り込んで、概略以下の構成でお届けします。

目次

イントロダクション

  • 非小細胞肺癌
  • 当レポートの概要

各地域における治験状況

  • 各国の治験数と平均被験者数
    • アジア太平洋地域の主要5ヶ国
    • 欧州の主要5ヶ国
    • 北米の主要国
    • 中東アフリカの主要5ヶ国

G7諸国での治験

G7諸国での治験:フェーズ(相)別

G7諸国での治験:進捗状況別

E7諸国での治験

E7諸国での治験:フェーズ(相)別

E7諸国での治験:進捗状況別

フェーズ(相)別の治験

  • 進行中の治験:フェーズ別

進捗状況別の治験

一定期間に採用された被験者

スポンサーの種類別の治験

有望なスポンサー

  • 非小細胞肺癌治療薬の治験に参加している上位企業

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • F. Hoffmann-La Roche Ltd.
    • Eli Lilly and Company
    • AstraZeneca PLC
    • Pfizer Inc.
    • Bristol-Myers Squibb Company
    • Sanofi
    • Novartis AG
    • Merck & Co., Inc
    • GlaxoSmithKline plc
    • C. H. Boehringer Sohn AG & Co. KG
  • 代表的な病院・研究機関の治験の概要
    • National Cancer Institute
    • The University of Texas M. D. Anderson Cancer Center
    • Memorial Sloan Kettering Cancer Center
    • West Japan Oncology Group
    • European Organization for Research and Treatment of Cancer
    • Radiation Therapy Oncology Group
    • Sun Yat-sen University
    • Eastern Cooperative Oncology Group
    • Sarah Cannon Research Institute
    • Barbara Ann Karmanos Cancer Institute

5つの代表的な治験のプロファイル

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC2057CTIDB

GlobalData's clinical trial report, "Non-Small Cell Lung Cancer Global Clinical Trials Review, H1, 2014" provides data on the Non-Small Cell Lung Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non-Small Cell Lung Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Non-Small Cell Lung Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Non-Small Cell Lung Cancer
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Non-Small Cell Lung Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Non-Small Cell Lung Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Non-Small Cell Lung Cancer
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Non-Small Cell Lung Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Non-Small Cell Lung Cancer
    • Mar 02, 2014: Genentech Provides Update on Phase III Study of Onartuzumab in People with Specific Type of Lung Cancer
    • Feb 19, 2014: Lilly Announces Ramucirumab Phase III Lung Cancer Trial Meets Primary Endpoint of Overall Survival
    • Feb 17, 2014: Afatinib: added benefit depends on mutation status
    • Jan 27, 2014: Pfizer Announces Top-Line Results From Two Phase 3 Trials Of Dacomitinib In Patients With Refractory Advanced Non-Small Cell Lung Cancer
    • Jan 16, 2014: ArQule Provides Updates on Clinical Trials in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer with Tivantinib
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • AstraZeneca PLC
      • Clinical Trial Overview of AstraZeneca PLC
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Bristol-Myers Squibb Company
      • Clinical Trial Overview of Bristol-Myers Squibb Company
      • Sanofi
      • Clinical Trial Overview of Sanofi
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • GlaxoSmithKline plc
      • Clinical Trial Overview of GlaxoSmithKline plc
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
    • Clinical Trial Overview of Top Institutes / Government
      • National Cancer Institute
      • Clinical Trial Overview of National Cancer Institute
      • The University of Texas M. D. Anderson Cancer Center
      • Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
      • Memorial Sloan Kettering Cancer Center
      • Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
      • West Japan Oncology Group
      • Clinical Trial Overview of West Japan Oncology Group
      • European Organization for Research and Treatment of Cancer
      • Clinical Trial Overview of European Organization for Research and Treatment of Cancer
      • Radiation Therapy Oncology Group
      • Clinical Trial Overview of Radiation Therapy Oncology Group
      • Sun Yat-sen University
      • Clinical Trial Overview of Sun Yat-sen University
      • Eastern Cooperative Oncology Group
      • Clinical Trial Overview of Eastern Cooperative Oncology Group
      • Sarah Cannon Research Institute
      • Clinical Trial Overview of Sarah Cannon Research Institute
      • Barbara Ann Karmanos Cancer Institute
      • Clinical Trial Overview of Barbara Ann Karmanos Cancer Institute
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Non-Small Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Non-Small Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Non-Small Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by West Japan Oncology Group, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by European Organization for Research and Treatment of Cancer, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Radiation Therapy Oncology Group, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Barbara Ann Karmanos Cancer Institute, 2014*

List of Figures

  • Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Non-Small Cell Lung Cancer to Oncology Clinical Trials, G7 Countries (%), 2014*
  • Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Non-Small Cell Lung Cancer to Oncology Clinical Trials, E7 Countries (%), 2014*
  • Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Non-Small Cell Lung Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Non-Small Cell Lung Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Non-Small Cell Lung Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top